Abstract
Precision healthcare company Color announced two separate deals that further its mission of bringing low-cost, data-driven clinical genetics to health system partners. In a new partnership, it will collaborate with rural health system Sanford Health to further develop its Imagenetics program, and it also announced an expansion of its existing partnership with NorthShore University HealthSystem to include an additional 30 clinics.
With Sanford Health, Color said it will help the health system migrate its Imagenetics genetic medicine program—which it launched in 2014—from using an array-based platform to one that uses next-generation sequencing (NGS) testing. Sanford will further leverage Color's suite of clinical tools designed to engage patients for broader adoption of genetic testing, while also streamlining clinical reporting within Sanford's locations in North Dakota, South Dakota, and Minnesota.
With NorthShore University HealthSystem (NorthShore), Color announced that the one-year-old partnership would expand to an additional 30 clinics within the system in 2020, along with its newest partner, Swedish Hospital, and would include providing polygenic risk score (PRS) information for type 2 diabetes and coronary artery disease to help guide care.
metamorworks / iStock / Getty Images Plus
